|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 413/04 | |
| C07D 413/14 | |||
| A61K 31/42 | |||
| A61K 31/4245 | |||
| A61K 31/44 | |||
| A61P 3/00 |
| (11) | Number of the document | 2205595 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08804779.0 |
| Date of filing the European patent application | 2008-09-26 | |
| (97) | Date of publication of the European application | 2010-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/062900 |
| Date | 2008-09-26 |
| (87) | Number | WO 2009/040410 |
| Date | 2009-04-02 |
| (30) | Number | Date | Country code |
| 976064 P | 2007-09-28 | US |
| (72) |
KWAK, Young-Shin, US
COPPOLA, Gary Mark, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |
| OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS |